Skip to main content
. 2019 Mar 28;104(11):2206–2214. doi: 10.3324/haematol.2018.214809

Figure 4.

Figure 4.

Overall survival (OS) (A) and event-free survival (EFS) (B) for the entire patient cohort (n=450). (A) The green line depicts the chronic myeloid leukemia (CML)-OS, whereas the blue line shows the OS. (B) EFS was calculated from the first year in sustained molecular response (MR)-3 (sMR3) (red vertical line indicates time of sMR3, i.e. time at which MR3 was sustained for 12 months).